Joshua Cohen - Global Med Affairs, Teva Pharmaceut Ind

基本信息

浏览量：1

职业迁徙

个人简介

暂无内容

研究兴趣

论文共 262 篇作者统计合作学者相似作者

按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选

Clinical Characteristics and Patient-Reported Outcomes of Chronic and Episodic Migraine Patients at a US Tertiary Headache Center: A Retrospective Observational Study

Zubair Ahmed,Ryan Honomichl,Stephen F. Thompson,Joshua M. Cohen,Andrew Schuster,Nicolas R. Thompson,Brittany Lapin,Belinda L. Udeh,Verena Ramirez Campos,Lynda J. Krasenbaum,Irene L. Katzan

Headacheno. 7 (2023): 908-916

引用0浏览0WOS引用

Burden of Migraine with Acute Medication Overuse or Psychiatric Comorbidities and Treatment with CGRP Pathway-Targeted Monoclonal Antibodies: A Review

Christopher Rhyne,Joshua M. Cohen,Michael J. Seminerio,Karen Carr,Lynda J. Krasenbaum

MEDICINEno. 23 (2023)

引用0浏览0引用

086 Long-term Efficacy of Fremanezumab in Migraine Patients with Inadequate Response to Prior Preventive Medication Classes

Steffen Naegel,Joshua Cohen,Verena Ramirez Campos,Steve Barash,Xiaoping Ning,Dalbir Dhiraj,David Kudrow

Journal of neurology, neurosurgery and psychiatryno. 9 (2022): e2.36-e2.36

引用0浏览0引用

Burden of Migraine in Brazil: A Cross‐sectional Real‐world Study

Marcio Nattan Portes Souza,Joshua M. M. Cohen, Tony Piha,Rinat Ribalov,Tamar Lengil, Andressa van der Laan,Marcelo Calderaro,Lulu K. K. Lee

Headache（2022）

引用1浏览0WOS引用

Timing and Location of Injection-site Adverse Events with Fremanezumab in Patients with Migraine: A Pooled Analysis of Phase 3 Studies (P16-2.003)

Holle Lee Dagny,Yoel Kessler,Verena Ramirez Campos,Xiaoping Ning,Joshua M. Cohen,Steve Barash, Tim Jürgens

Neurologyno. 18_supplement (2022)

引用0浏览0引用

Reducing the Burden of Migraine: Safety and Efficacy of CGRP Pathway-Targeted Preventive Treatments

George R. Nissan, Richard Kim,Joshua M. Cohen,Michael J. Seminerio,Lynda J. Krasenbaum,Karen Carr,Vincent Martin

Journal of clinical medicine（2022）

引用4浏览0引用

Adverse Events Reported with Therapies Targeting the CGRP Pathway During the First 6 Months Post-launch: A Retrospective Analysis Using the FDA Adverse Events Reporting System

Stephen D. Silberstein,Shoshana Reshef,Joshua M. Cohen,Sanjay Gandhi,Michael Seminerio,Verena Ramirez Campos,Yoel Kessler,Stephen F. Thompson,Andrew Blumenfeld

Advances in Therapy（2022）

引用2浏览0WOS引用

Efficacy and Quality-of-life Improvements with Fremanezumab Treatment in Patients with Difficult-to-treat Migraine with Associated Neurological Dysfunction

Christian Lampl,Alan M. Rapoport,Joshua M. Cohen,Steve Barash,Verena Ramirez Campos,Michael J. Seminerio,Xiaoping Ning,Stephen D. Silberstein

European journal of neurology（2022）

引用0浏览0WOS引用

Changes in Heart Rate and Blood Pressure in Participants Treated with Fremanezumab for Migraine: A Pooled Analysis of Phase 3 Studies (P3-2.003)

Steffen Naegel,Joshua M. Cohen,Yoel Kessler,Verena Ramirez Campos,Steve Barash,Xiaoping Ning,Stephanie J. Nahas

Neurologyno. 18_supplement (2022)

引用0浏览0引用

Real-world Effectiveness of Fremanezumab in Migraine Patients Initiating Treatment in the United States: Results from a Retrospective Chart Study

Driessen Maurice T.,Cohen Joshua M.,Patterson-Lomba Oscar,Thompson Stephen F.,Seminerio Michael,Carr Karen,Totev Todor I.,Sun Rochelle,Yim Erica,Mu Fan,Ayyagari Rajeev

The Journal of Headache and Pain（2022）

引用9浏览0WOS引用

加载更多

作者统计

合作学者

合作机构

D-Core

合作者
学生
导师

暂无相似学者，你可以通过学者研究领域进行搜索筛选

数据免责声明

页面数据均来自互联网公开来源、合作出版商和通过AI技术自动分析结果，我们不对页面数据的有效性、准确性、正确性、可靠性、完整性和及时性做出任何承诺和保证。若有疑问，可以通过电子邮件方式联系我们：report@aminer.cn